Form 8-K - Current report:
SEC Accession No. 0001558370-25-003374
Filing Date
2025-03-20
Accepted
2025-03-20 16:05:19
Documents
15
Period of Report
2025-03-14
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rytm-20250314x8k.htm   iXBRL 8-K 37210
2 EX-99.1 rytm-20250314xex99d1.htm EX-99.1 31927
3 GRAPHIC rytm-20250314xex99d1001.jpg GRAPHIC 5104
  Complete submission text file 0001558370-25-003374.txt   205093

Data Files

Seq Description Document Type Size
4 EX-101.SCH rytm-20250314.xsd EX-101.SCH 3420
5 EX-101.LAB rytm-20250314_lab.xml EX-101.LAB 15926
6 EX-101.PRE rytm-20250314_pre.xml EX-101.PRE 10324
17 EXTRACTED XBRL INSTANCE DOCUMENT rytm-20250314x8k_htm.xml XML 4857
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 25756446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)